Omicron variant study could contribute to future vaccine development

  • December 13, 2022
Omicron variant study could contribute to future vaccine development

Antonia Netzl is co-author of a study on Covid variants which has implications for vaccine development

Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants.

Antonia Netzl et al

All the omicron strains are different from the original COVID infection and from each other, but repeated exposure to pre-omicron variants can protect against omicron variants, according to a new study which has implications for further vaccine development.

The study, BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants, is published in Nature Communications today and is co-authored by Gates Cambridge Scholar Antonia Netzl.

It looked at the original omicron variant [BA.1] and sought to compare whether the BA.2 and BA.5 sub-variants which soon replaced it in many countries were more resistant to COVID vaccines.

Using people with differing histories of exposure to infection and vaccination, they found that unvaccinated people had limited cross-neutralising antibodies to pre-omicron variants and BA.1 after a single exposure to BA.2.

By mapping all variants of concern and the omicron sub-variants, they showed that all the omicron sub-variants are distinct to pre-omicron variants, but that the three omicron variants are also antigenically distinct from each other.

Moreover, antibodies that can fight the virus are only generated after three or more exposures to antigenically close variants and also after two exposures to antigenically distant variants.

They say: “Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants. It suggests that cross-neutralisation improves with repeated exposure and an increase in absolute titers of antibodies and that exposure to two distant variants has protective potential against emerging variants with some degree of similarity to currently and previously circulating Variants of Concern.”

*Picture credit: https://www.vperemen.comCC BY-SA 4.0 and Wikimedia Commons.

 

Latest News

Celebrating agricultural innovation in Africa

A foundation started by a Gates Cambridge Scholar is leading a Cambridge Festival event in March to celebrate agricultural innovation in Africa where a new project on food security will be launched. The Agri-Innovation & Impact Project (AGRIIP) will be launched at the Roots of Resilience event on 27th March. It is designed to empower […]

What makes Earth tick

It was during his master’s that Alex Myhill [2022] was introduced to Earth Science and realised just how much we don’t understand about the Earth. He wanted to explore further and his PhD seeks to understand the dynamics that make the Earth tick. He is developing new techniques for the efficient computation of whole Earth […]

25th anniversary panel to speak at Cambridge Festival

Five Scholars will speak about their ideas that could change the world at this year’s Cambridge Festival as part of the ongoing celebrations for Gates Cambridge’s 25th anniversary. The Festival programme has been published today and includes the Gates Cambridge event – Ideas that could change the world – hosted by international journalist Catherine Galloway […]

Study shows need for repeated vaccines for immunocompromised people

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, according to new research from the University of Cambridge led by a Gates Cambridge Scholar. The findings, published today in Science Advances, suggest that such individuals will need regular vaccine […]